Stephen J Russell
Overview
Explore the profile of Stephen J Russell including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
348
Citations
12608
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Jiang H, Nace R, Ferguson C, Zhang L, Peng K, Russell S
Cell Rep Med
. 2024 Dec;
6(1):101874.
PMID: 39694038
Cytomegalovirus (CMV) infects a wide range of cell types, including tumor-associated myeloid cells and glioma cells. Clinical observations suggest a potential link between long-term glioblastoma survival and CMV reactivation. We...
2.
Tonne J, Budzik K, Carrasco T, Ebbert L, Thompson J, Nace R, et al.
Mol Ther Oncol
. 2024 Sep;
32(3):200852.
PMID: 39220111
Chimeric antigen receptor (CAR) T cells have had limited success against solid tumors. Here, we used an oncolytic foamy virus (oFV) to display a model CAR target antigen (CD19) on...
3.
Daglish J, Blacker A, de Boer G, Russell S, Tausif M, Hose D, et al.
Org Process Res Dev
. 2024 May;
28(5):1979-1989.
PMID: 38783854
Presented here is the design and performance of a coalescing liquid-liquid filter, based on low-cost and readily available meltblown nonwoven substrates for separation of immiscible phases. The performance of the...
4.
Phillips M, Tronci G, Pask C, Russell S
Polymers (Basel)
. 2024 Apr;
16(7).
PMID: 38611127
Implantable hydrogels should ideally possess mechanical properties matched to the surrounding tissues to enable adequate mechanical function while regeneration occurs. This can be challenging, especially when degradable systems with a...
5.
Jiang H, Nace R, Carrasco T, Zhang L, Peng K, Russell S
J Immunother Cancer
. 2024 Mar;
12(3).
PMID: 38527762
Background: The varicella-zoster virus (VZV), belonging to the group of human α-herpesviruses, has yet to be developed as a platform for oncolytic virotherapy, despite indications from clinical case reports suggesting...
6.
Wheldrake A, Guillemois E, Arouni H, Chetty V, Zappa E, Russell S
Malar J
. 2024 Jan;
23(1):19.
PMID: 38218962
Background: For at least a decade, concerns have been raised about the physical durability of insecticide-treated nets (ITNs) and their ability to remain in good condition for at least three...
7.
Munoz-Alia M, Nace R, Balakrishnan B, Zhang L, Packiriswamy N, Singh G, et al.
mBio
. 2024 Jan;
15(2):e0292823.
PMID: 38193729
Serum titers of SARS-CoV-2-neutralizing antibodies (nAbs) correlate well with protection from symptomatic COVID-19 but decay rapidly in the months following vaccination or infection. In contrast, measles-protective nAb titers are lifelong...
8.
Makielski K, Sarver A, Henson M, Stuebner K, Borgatti A, Suksanpaisan L, et al.
Mol Ther Oncolytics
. 2023 Nov;
31:100736.
PMID: 37965295
Osteosarcoma is a devastating bone cancer that disproportionally afflicts children, adolescents, and young adults. Standard therapy includes surgical tumor resection combined with multiagent chemotherapy, but many patients still suffer from...
9.
Jiang H, Nace R, Ariail E, Ma Y, McGlinch E, Ferguson C, et al.
Mol Ther
. 2023 Nov;
32(1):241-256.
PMID: 37927036
Oncolytic virotherapy aims to activate host antitumor immunity. In responsive tumors, intratumorally injected herpes simplex viruses (HSVs) have been shown to lyse tumor cells, resulting in local inflammation, enhanced tumor...
10.
Makielski K, Sarver A, Henson M, Stuebner K, Borgatti A, Suksanpaisan L, et al.
bioRxiv
. 2023 May;
PMID: 37131624
Osteosarcoma is a devastating bone cancer that disproportionally afflicts children, adolescents, and young adults. Standard therapy includes surgical tumor resection combined with multiagent chemotherapy, but many patients still suffer from...